186 related articles for article (PubMed ID: 25863943)
1. Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.
Willemen Y; Van den Bergh JM; Lion E; Anguille S; Roelandts VA; Van Acker HH; Heynderickx SD; Stein BM; Peeters M; Figdor CG; Van Tendeloo VF; de Vries IJ; Adema GJ; Berneman ZN; Smits EL
Cancer Immunol Immunother; 2015 Jul; 64(7):831-42. PubMed ID: 25863943
[TBL] [Abstract][Full Text] [Related]
2. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.
Tosi D; Valenti R; Cova A; Sovena G; Huber V; Pilla L; Arienti F; Belardelli F; Parmiani G; Rivoltini L
J Immunol; 2004 May; 172(9):5363-70. PubMed ID: 15100276
[TBL] [Abstract][Full Text] [Related]
3. An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA-loaded dendritic cells for cancer vaccination.
Brabants E; Heyns K; De Smet S; Devreker P; Ingels J; De Cabooter N; Debacker V; Dullaers M; VAN Meerbeeck JP; Vandekerckhove B; Vermaelen KY
Cytotherapy; 2018 Sep; 20(9):1164-1181. PubMed ID: 30122654
[TBL] [Abstract][Full Text] [Related]
4. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.
Mohty M; Vialle-Castellano A; Nunes JA; Isnardon D; Olive D; Gaugler B
J Immunol; 2003 Oct; 171(7):3385-93. PubMed ID: 14500632
[TBL] [Abstract][Full Text] [Related]
5. Targeting of the WT1
Dagvadorj N; Deuretzbacher A; Weisenberger D; Baumeister E; Trebing J; Lang I; Köchel C; Kapp M; Kapp K; Beilhack A; Hünig T; Einsele H; Wajant H; Grigoleit GU
Cancer Immunol Immunother; 2017 Mar; 66(3):319-332. PubMed ID: 27896368
[TBL] [Abstract][Full Text] [Related]
6. Induction of antigen-specific CD8+ cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA.
Michiels A; Breckpot K; Corthals J; Tuyaerts S; Bonehill A; Heirman C; Thielemans K; Aerts JL
Gene Ther; 2006 Jul; 13(13):1027-36. PubMed ID: 16511519
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination.
van Beek JJ; Wimmers F; Hato SV; de Vries IJ; Sköld AE
Crit Rev Immunol; 2014; 34(6):517-36. PubMed ID: 25597314
[TBL] [Abstract][Full Text] [Related]
8. Induction of antigen-specific cytotoxic T lymphocytes by using monocyte-derived DCs transfected with in vitro-transcribed WT1 or SART1 mRNA.
Narita M; Tochiki N; Saitoh A; Watanabe N; Kaji M; Satoh N; Yamahira A; Nakamura T; Masuko M; Furukawa T; Toba K; Fuse I; Aizawa Y; Takahashi M
Med Oncol; 2009 Dec; 26(4):429-36. PubMed ID: 19058036
[TBL] [Abstract][Full Text] [Related]
9. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
10. IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity.
Lattanzi L; Rozera C; Marescotti D; D'Agostino G; Santodonato L; Cellini S; Belardelli F; Gavioli R; Ferrantini M
Immunobiology; 2011 May; 216(5):537-47. PubMed ID: 21093097
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells cross-talk with tumour antigen-specific CD8
Eiraku Y; Terunuma H; Yagi M; Deng X; Nicol AJ; Nieda M
Clin Exp Immunol; 2018 Oct; 194(1):54-66. PubMed ID: 30009488
[TBL] [Abstract][Full Text] [Related]
12. Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins.
Van Gulck ER; Ponsaerts P; Heyndrickx L; Vereecken K; Moerman F; De Roo A; Colebunders R; Van den Bosch G; Van Bockstaele DR; Van Tendeloo VF; Allard S; Verrier B; Marañón C; Hoeffel G; Hosmalin A; Berneman ZN; Vanham G
Blood; 2006 Mar; 107(5):1818-27. PubMed ID: 16263796
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy with interferon-α-induced dendritic cells for chronic HCV infection (the results of pilot clinical trial).
Chernykh E; Leplina O; Oleynik E; Tikhonova M; Tyrinova T; Starostina N; Ostanin A
Immunol Res; 2018 Feb; 66(1):31-43. PubMed ID: 29164490
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta.
Dalod M; Hamilton T; Salomon R; Salazar-Mather TP; Henry SC; Hamilton JD; Biron CA
J Exp Med; 2003 Apr; 197(7):885-98. PubMed ID: 12682109
[TBL] [Abstract][Full Text] [Related]
15. Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.
Santodonato L; D'Agostino G; Nisini R; Mariotti S; Monque DM; Spada M; Lattanzi L; Perrone MP; Andreotti M; Belardelli F; Ferrantini M
J Immunol; 2003 May; 170(10):5195-202. PubMed ID: 12734367
[TBL] [Abstract][Full Text] [Related]
16. Natural killer-dendritic cell cross-talk in cancer immunotherapy.
Kalinski P; Mailliard RB; Giermasz A; Zeh HJ; Basse P; Bartlett DL; Kirkwood JM; Lotze MT; Herberman RB
Expert Opin Biol Ther; 2005 Oct; 5(10):1303-15. PubMed ID: 16197336
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells.
Shinagawa N; Yamazaki K; Tamura Y; Imai A; Kikuchi E; Yokouchi H; Hommura F; Oizumi S; Nishimura M
Cancer Immunol Immunother; 2008 Feb; 57(2):165-74. PubMed ID: 17628800
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients.
Van Nuffel AM; Benteyn D; Wilgenhof S; Pierret L; Corthals J; Heirman C; van der Bruggen P; Coulie PG; Neyns B; Thielemans K; Bonehill A
Mol Ther; 2012 May; 20(5):1063-74. PubMed ID: 22371843
[TBL] [Abstract][Full Text] [Related]
19. Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.
Tel J; Schreibelt G; Sittig SP; Mathan TS; Buschow SI; Cruz LJ; Lambeck AJ; Figdor CG; de Vries IJ
Blood; 2013 Jan; 121(3):459-67. PubMed ID: 23212525
[TBL] [Abstract][Full Text] [Related]
20. Modulation of regulatory T cell function by monocyte-derived dendritic cells matured through electroporation with mRNA encoding CD40 ligand, constitutively active TLR4, and CD70.
Pen JJ; De Keersmaecker B; Maenhout SK; Van Nuffel AM; Heirman C; Corthals J; Escors D; Bonehill A; Thielemans K; Breckpot K; Aerts JL
J Immunol; 2013 Aug; 191(4):1976-83. PubMed ID: 23842750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
